Latest on Lupus from the LRI

July 9, 2015

Exhausting the Immune System Points the Way to Better Long-Term Outcomes and Treatments for Lupus Patients

More News from the Lupus Community

August 31, 2015

Janus Biotherapeutics collaborating with pharmaceutical giant Roche to develop toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases – including lupus.